Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472582 (US10829487, Example I-61) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472647 (US10829487, Example I-130) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472670 (US10829487, Example I-177) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472539 (US10829487, Example I-19) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472653 (US10829487, Example I-160) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472651 (US10829487, Example I-158) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472645 (US10829487, Example I-128) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472642 (US10829487, Example I-125) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472641 (US10829487, Example I-124) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472606 (US10829487, Example I-89) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472605 (US10829487, Example I-88) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472581 (US10829487, Example I-60) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472579 (US10829487, Example I-58) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472578 (US10829487, Example I-57) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472540 (US10829487, Example I-20) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472592 (US10829487, Example I-73) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472610 (US10829487, Example I-93) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472541 (US10829487, Example I-21) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472639 (US10829487, Example I-122) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472640 (US10829487, Example I-123) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472580 (US10829487, Example I-59) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472652 (US10829487, Example I-159) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472625 (US10829487, Example I-108) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472633 (US10829487, Example I-116) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472522 (US10829487, Example I-2) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472574 (US10829487, Example I-53) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472573 (US10829487, Example I-52) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472559 (US10829487, Example I-38) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472543 (US10829487, Example I-23) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472623 (US10829487, Example I-106) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472621 (US10829487, Example I-104) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472619 (US10829487, Example I-102) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472618 (US10829487, Example I-101) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472609 (US10829487, Example I-92) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472608 (US10829487, Example I-91) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472607 (US10829487, Example I-90) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472604 (US10829487, Example I-87) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472649 (US10829487, Example I-156) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472521 (US10829487, Example I-1) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472523 (US10829487, Example I-3) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472531 (US10829487, Example I-11) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472537 (US10829487, Example I-17) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472538 (US10829487, Example I-18) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472558 (US10829487, Example I-37) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472564 (US10829487, Example I-43) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472575 (US10829487, Example I-54) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472599 (US10829487, Example I-82) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472611 (US10829487, Example I-94) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472612 (US10829487, Example I-95) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049] () | BDBM472620 (US10829487, Example I-103) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description Compounds are diluted to a final start concentration of 100 μM and are tested in duplicate. Assay-ready plates (ARPs) are generated using an Acc... | US Patent US10829487 (2020) BindingDB Entry DOI: 10.7270/Q2D50R22 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 237 total ) | Next | Last >> |